+

WO2005113512A1 - Process for the preparation of 1,2-diamines - Google Patents

Process for the preparation of 1,2-diamines Download PDF

Info

Publication number
WO2005113512A1
WO2005113512A1 PCT/IB2005/001363 IB2005001363W WO2005113512A1 WO 2005113512 A1 WO2005113512 A1 WO 2005113512A1 IB 2005001363 W IB2005001363 W IB 2005001363W WO 2005113512 A1 WO2005113512 A1 WO 2005113512A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
diamine
hydrogen
pure
dihydroimidazole
Prior art date
Application number
PCT/IB2005/001363
Other languages
French (fr)
Inventor
Yatendra Kumar
Mohan Prasad
Keshav Deo
Killol Patel
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of WO2005113512A1 publication Critical patent/WO2005113512A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/44—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of carboxylic acids or esters thereof in presence of ammonia or amines, or by reduction of nitriles, carboxylic acid amides, imines or imino-ethers
    • C07C209/48—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of carboxylic acids or esters thereof in presence of ammonia or amines, or by reduction of nitriles, carboxylic acid amides, imines or imino-ethers by reduction of nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/62—Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms

Definitions

  • the field of the invention relates to processes for the preparation of 1,2-diamines, and to the use of these compounds as intermediates for the preparation of several useful compounds. More particularly, it relates to the preparation of 2-methyl-l,2- diaminopropane which is a useful intermediate for the preparation of pharmaceutically active compounds. Background of the Invention 1,2-diamines of Formula I, or salts thereof,
  • Formula I wherein R l5 R 2 and R 3 are hydrogen or Ci to C 6 straight or branched chain alkyl group, are useful intermediates in the synthesis of several drugs, herbicides, agricultural products, dyes and cosmetics.
  • Host of patents describe the use of 1,2-diamines as intermediates for example, in U.S. Patent Nos. 2,500,600; 3,725,443; 3,770,766; 3,928,412; 4,810,717; 4,935,421; 4,935,422; 3,931,218; 4,128,655; 4,303,649 4,260,626; 5,596,002; DE 2,341,289 and DE 2,408,334.
  • 2004/0039008 describes the use of 2-methyl-l,2-diaminopropane of Formula I, wherein R ⁇ and R are methyl and R 3 is hydrogen, in the preparation of novel anti-malarial compound OZ-277, which is a dispiro-l,2,4-trioxolane derivative.
  • novel anti-malarial compound OZ-277 which is a dispiro-l,2,4-trioxolane derivative.
  • Several processes have been reported for the preparation of 1,2-diamines for example, Berischte 1932, 65B, 710-713 and 1933, 66B, 1330-1333. These processes disclose the preparation of 1,2-diamines by reducing ⁇ -aminonitriles using a palladium catalyst at pressures in excess of 355 pounds per square inch (PSI).
  • PSI pounds per square inch
  • Journal of Chemical Society, Abstracts, 1934, 49-50 discloses a process for the preparation of 1,2-diamines by oximation of alkylene compounds followed by reduction of the aldoximes using sodium amalgam (Na/Ffg).
  • Journal of American Chemical Society 1948, 70, 184-186 describes a process of converting 2-cyanoalkanes to 1 ,2-diamines by the reaction of homologs of ethylenimine with amines and liquid ammonia in the presence of ammonium chloride as a catalyst at elevated temperatures and pressures.
  • Journal of American Chemical Society I960, 82, 696-698 discloses a process for the preparation of 1,2-diamines by reduction of corresponding c-aminonitriles using alcoholic hydrogen chloride over platinum oxide at low pressures.
  • U.S. Patent No. 2,408,171 discloses the preparation of 2-methyl-l, 2- propanediamine by reacting 2-methyl-2-nitro-l-propanol with ammonia in the presence of a suitable hydrogenation catalyst under hydrogen pressure of about 1100 PSI at 40°C to get 2-methyl- 1,2-diaminopropane.
  • 2,413,248 describes the preparation of N-(2- aminoisobutyl)benzylamine by reducing N-(2-nitroisobutyl)-benzylamine in methanol using Raney nickel at 500 PSI hydrogen pressure.
  • U.S. Patent No. 2,587,043 describes a process for the preparation of 1,2- primarydiamines by acylating an alpha aminonitrile compound, forming the dihydroimidazole by catalytically hydrogenating acylated aminonitrile with gaseous hydrogen in the presence of ammonia or ammonium compounds and forming the diprimary diamine by hydrolyzing the dihydroimidazole.
  • U.S. Patent No. 4,902,831 describes a process for the preparation of 1,2- diaminoethane compounds which comprises reacting a Schiff base with a nitroalkane in the presence of a catalytic amount of an inorganic base to form a substituted or unsubstituted l-nitro-2-aminoethane which is then hydro genated to obtain the corresponding 1,2-diaminoethane compound.
  • Japanese Patent Application JP 08-027072 A2 describes a process for the preparation of 2-methyl- 1 ,2-propanediamine which can be used for the preparation of compounds containing dihydroimidazole ring by hydrogenating 2-acetyl-amino-2-methyl- propanenitrile in the presence of Raney nickel catalyst and in the absence of ammonia. These processes require high-pressure conditions usually in the range of 300 to 2500 PSI or use of nitro compounds, which are highly inflammable and toxic. The purity of 1,2-diamines obtained by above mentioned prior-art is poor, the product obtained is very hygroscopic and difficult to purify without significantly affecting the yields.
  • the invention provides a process which does not result in impure product; rather pure 1,2-diamines having purity more than 99% by GC is obtained.
  • the process is simple, cost-effective, which does not require high pressure and provide pure non- hygroscopic product thus making the process amenable for commercial use.
  • R ls R 2 and R 3 are hydrogen or Ci to C 6 straight or branched chain alkyl group.
  • the process includes a) hydrogenating acetylamino-nitrile of Formula II,
  • R l5 R 2 and R 3 are as defined above and R 4 is hydrogen or Ci to C 6 straight or branched chain alkyl group, with a metal catalyst in the presence of ammonia or chemical equivalents thereof, at a hydrogen gas pressure of about 40 PSI to about 250 PSI, in an organic solvent to get a dihydroimidazole of Formula III,
  • R 3 is hydrogen and R 4 is hydrogen or to C 6 straight or branched chain alkyl group, with a metal catalyst in the presence of ammonia or chemical equivalents thereof, at a pressure of about 40 PSI to about 250 PSI in an organic solvent to get a dihydroimidazole of Formula III, wherein R l3 R 2 , R 3 and R 4 are as defined above; and b) hydrolyzing the dihydroimidazole of Formula III in the presence of a base to get 2- methyl-l,2-diaminopropane of Formula I, or a salt thereof, wherein Ri and R 2 are methyl and R 3 is hydrogen.
  • a process for preparing pure 1,2- diamine of Formula I, or a salt thereof includes drying 1,2-diamine over a solid base and then distilling over a solid base to get the pure 1,2-diamine having a purity of more than 99% by GC.
  • the process may produce the pure 1,2-diamine having a purity of more than 99% by GC.
  • it may produce 1,2-diamine having a purity of more than 99.5%, for example more than 99.8% by GC.
  • the pure 1,2-diamine of Formula I, or a salt thereof may have, for example moisture content less than 1% w/w. In particular, it may have moisture content less than 0.5%) w/w, for example less than 0.3% w/w.
  • the resulting pure 1,2-diamine of Formula I, or a salt thereof may be used as an intermediate for the preparation of dyes, enamels, varnishes, fungicides, bactericides, resins, herbicides, hypoglycemic agents, 3-adrenergic blockers, antipyretics, anti- depressants, anti-diabetics, anti-inflammatory, antimalarials, ulcer-inhibitors, anti- arrhythmic, antihypertensive, anti-secretory compounds, and the like.
  • the process involves hydrogenating acetylamino- nitrile of Formula II, wherein R ls R 2 and R 3 are as defined above and R t is hydrogen or Ci to C 6 straight or branched chain alkyl group, with a metal catalyst in the presence of ammonia or chemical equivalents thereof, at a hydrogen gas pressure of about 40 PSI to about 250 PSI, in an organic solvent to get a dihydroimidazole of Formula III, wherein R l5 R 2 , R 3 and R 4 are as defined above.
  • the dihydroimidazole of Formula III is hydrolyzed in the presence of a base to get 1,2-diamine of Formula I, or a salt thereof.
  • the hydrogenation reaction may be carried at a temperature from about 40 °C to about 180°C. In particular, it may be carried out at a temperature from about 60 °C to about 150°C.
  • metal catalysts which can be used in the hydrogenation reaction include catalysts such as Raney nickel, platinum and ruthenium.
  • Suitable organic solvents which can be used in the hydrogenation reaction of compound of Formula II are conventional solvents used in the hydrogenation reactions and are known to a person of ordinary skill in the art. Examples of such solvents include alcohols, inert polar aprotic solvents, dialkyl ether, paraffin oil, dowtherm, and the like.
  • ammonia or chemical equivalents thereof includes liquor ammonia, aqueous ammonia solution, ammonium hydroxide, ammonium chloride, ammonium sulphate, ammonium formate, and the like.
  • the reaction mixture may be cooled after the completion of the reaction, and may be treated with charcoal.
  • the reaction mixture may also be concentrated to reduce the volume of solvent before cooling.
  • the dihydroimidazole of Formula III thus obtained may be used as such for further hydrolysis. It may also be further purified by high vacuum distillation and the fractions corresponding to the pure dihydroimidazole of Formula III are collected separately and used for further hydrolysis reaction.
  • the hydrolysis of the dihydroimidazole of Formula III can be carried out in aqueous conditions using a base.
  • the reaction may also be carried out in the presence of an organic solvent.
  • the dihydroimidazole of Formula III can be treated with aqueous solution of a base at a temperature of from about 60 °C to 150°C.
  • the organic solvents which can be used in the hydrolysis reaction include water- soluble alcohols, low boiling polar aprotic solvents, water-soluble ketones, acetonitrile, and mixtures thereof.
  • Examples of a base which can be used in the hydrolysis reaction of dihydroimidazole of Formula III include alkali and alkaline earth metal hydroxides, carbonates, bicarbonates and alkoxides.
  • the organic solvent may be removed under vacuum and the 1,2-diamine product layer can be separated from the reaction mass by adding a solid base to the reaction mass.
  • the separated layer can be isolated and dried over solid base for about 10-12 hours.
  • the 1,2-diamine product may be further or additionally dried to achieve the desired moisture values.
  • the product may be dried by removing the solid base drying agent and adding fresh solid base.
  • the resultant mass can be stirred at about 35-40°C to reduce the moisture content to less than 1%.
  • the solid base drying agents which can be used include alkali metal hydroxide such as potassium hydroxide.
  • the inventors have also developed a process for the preparation of 2-methyl- 1,2- diaminopropane of Formula I, or a salt thereof, wherein Ri and R 2 are methyl and R 3 is hydrogen.
  • the process involves hydrogenating acetylamino-nitrile of Formula II, wherein R ⁇ and R 2 are methyl, R 3 is hydrogen and i is hydrogen or Ci to C 6 straight or branched chain alkyl group, with a metal catalyst in the presence of ammonia or chemical equivalents thereof, at a pressure of about 40 PSI to about 250 PSI in an organic solvent to get dihydroimidazole of Formula Ul, which is hydrolyzed in the presence of a base to get 2-methyl- 1,2-diaminopropane of Formula I, or a salt thereof, wherein Ri and R 2 are methyl and R 3 is hydrogen.
  • the product 1,2-diamine thus obtained may be used as an intermediate in the preparation of dyes, enamels, varnishes, fungicides, bactericides, resins, herbicides, hypoglycemic agents, /3-adrenergic blockers, anti-depressants, anti-inflammatory, antimalarials, ulcer-inhibitors, anti-arrhythmic, antihypertensive, anti-secretory compounds, and the like.
  • Acetylamino-nitrile of Formula II wherein, R l5 R 2 and R 3 are methyl and R is hydrogen or Ci to C 6 straight or branched chain alkyl group can be prepared by methods known in the art such as the process disclosed in U.S. Patent No. 2,587,043.
  • the present invention is further illustrated by the following examples which are provided merely to be exemplary of the invention and do not limit the scope of the invention. Certain modifications and equivalents will be apparent to those skilled in the art and are intended to be included within the scope of the present invention.
  • Example 1 Preparation of 2,4,4-trimethyl-2,3-dihydroimidazole hi a hydrogenator, N-acetyl-2-cyano-2-methylethylamine (100 gm) and methanol (300 ml) were added followed by addition of Raney Nickel catalyst (80 gm) and liquor ammonia solution (200 ml, 22-25% w/v in water). The vessel was closed and hydrogen gas was purged to achieve 6 Kg pressure. The temperature of the reaction mass was slowly raised up to 85°C. The reaction mass was strrred at 8 to 9 Kg hydrogen pressure at 85 to 90°C for 8 to 9 hrs.
  • reaction mass After confi ⁇ ning the completion of reaction by TLC, the reaction mass was cooled to 25 to 30°C and hydrogen was vented out. The reaction mass was removed from the hydrogenator and charcoal (10 gm) was charged to it. The resultant mass was filtered through a celite bed and the bed was washed with a small amount of methanol. The filtrate was concentrated under vacuum to remove methanol and the residue was distilled under vacuum of about 10 mm of Hg and the fraction distilling between 110- 130°C was collected and kept separately to give pure 2,4,4-trimethyl-2,3- dihydroimidazole.
  • Example 2 Preparation of 2-methyl- 1,2-propanediamine 2,4,4-trimethyl-2,3 -dihydroimidazole (100 gm) prepared per example 1 was added to a solution of potassium hydroxide (300 ml, 30% w/v in water). The resultant mixture was refmxed for about 6 to 7 hours. The completion of reaction was monitored by TLC. After this, the reaction mass was cooled to about 25-30°C. Solid potassium hydroxide (300 gm) was added to the cooled mass and stnred for about 30 minutes. The organic layer was separated and collected. Solid potassium hydroxide (10 gm) was added to the organic layer. The resultant mass was sti ⁇ ed further at 35 to 40°C for 10 to 12 hours.
  • Solid potassium hydroxide was filtered and the moisture content of the filtrate was checked. The process of adding solid potassium hydroxide and heating to 35-40°C was repeated till moisture content of not more than 1% was achieved. This gave substantially pure 2- methyl- 1,2-diamino ⁇ ropane.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to processes for the preparation of 1,2-diamines, and to the use of these compounds as intermediates for the preparation of several pharmaceutically active compounds. More particularly, it relates to the preparation of 2-methyl-1,2-diaminopropane. The process involves reductive cyclization of 1, 1 -cyanoanilide followed by hydrolysis of the resultant imidazole derivative to get 1,2-diamine.

Description

PROCESS FOR THE PREPARATION OF 1,2-DI AMINES Field of the Invention The field of the invention relates to processes for the preparation of 1,2-diamines, and to the use of these compounds as intermediates for the preparation of several useful compounds. More particularly, it relates to the preparation of 2-methyl-l,2- diaminopropane which is a useful intermediate for the preparation of pharmaceutically active compounds. Background of the Invention 1,2-diamines of Formula I, or salts thereof,
Figure imgf000002_0001
Formula I wherein Rl5 R2 and R3 are hydrogen or Ci to C6 straight or branched chain alkyl group, are useful intermediates in the synthesis of several drugs, herbicides, agricultural products, dyes and cosmetics. Host of patents describe the use of 1,2-diamines as intermediates for example, in U.S. Patent Nos. 2,500,600; 3,725,443; 3,770,766; 3,928,412; 4,810,717; 4,935,421; 4,935,422; 3,931,218; 4,128,655; 4,303,649 4,260,626; 5,596,002; DE 2,341,289 and DE 2,408,334. U.S. Patent Application No. 2004/0039008 describes the use of 2-methyl-l,2-diaminopropane of Formula I, wherein R\ and R are methyl and R3 is hydrogen, in the preparation of novel anti-malarial compound OZ-277, which is a dispiro-l,2,4-trioxolane derivative. Several processes have been reported for the preparation of 1,2-diamines for example, Berischte 1932, 65B, 710-713 and 1933, 66B, 1330-1333. These processes disclose the preparation of 1,2-diamines by reducing α-aminonitriles using a palladium catalyst at pressures in excess of 355 pounds per square inch (PSI). Journal of Chemical Society, Abstracts, 1934, 49-50 discloses a process for the preparation of 1,2-diamines by oximation of alkylene compounds followed by reduction of the aldoximes using sodium amalgam (Na/Ffg). Journal of American Chemical Society 1948, 70, 184-186 describes a process of converting 2-cyanoalkanes to 1 ,2-diamines by the reaction of homologs of ethylenimine with amines and liquid ammonia in the presence of ammonium chloride as a catalyst at elevated temperatures and pressures. Journal of American Chemical Society I960, 82, 696-698 discloses a process for the preparation of 1,2-diamines by reduction of corresponding c-aminonitriles using alcoholic hydrogen chloride over platinum oxide at low pressures. U.S. Patent No. 2,408,171 discloses the preparation of 2-methyl-l, 2- propanediamine by reacting 2-methyl-2-nitro-l-propanol with ammonia in the presence of a suitable hydrogenation catalyst under hydrogen pressure of about 1100 PSI at 40°C to get 2-methyl- 1,2-diaminopropane. U.S. Patent No. 2,413,248 describes the preparation of N-(2- aminoisobutyl)benzylamine by reducing N-(2-nitroisobutyl)-benzylamine in methanol using Raney nickel at 500 PSI hydrogen pressure. U.S. Patent No. 2,587,043 describes a process for the preparation of 1,2- primarydiamines by acylating an alpha aminonitrile compound, forming the dihydroimidazole by catalytically hydrogenating acylated aminonitrile with gaseous hydrogen in the presence of ammonia or ammonium compounds and forming the diprimary diamine by hydrolyzing the dihydroimidazole. The process requires a hydrogen pressure of about 500 PSI to 2500 PSI at a temperature of about 90-100°C. U.S. Patent No. 4,902,831 describes a process for the preparation of 1,2- diaminoethane compounds which comprises reacting a Schiff base with a nitroalkane in the presence of a catalytic amount of an inorganic base to form a substituted or unsubstituted l-nitro-2-aminoethane which is then hydro genated to obtain the corresponding 1,2-diaminoethane compound. Japanese Patent Application JP 08-027072 A2 describes a process for the preparation of 2-methyl- 1 ,2-propanediamine which can be used for the preparation of compounds containing dihydroimidazole ring by hydrogenating 2-acetyl-amino-2-methyl- propanenitrile in the presence of Raney nickel catalyst and in the absence of ammonia. These processes require high-pressure conditions usually in the range of 300 to 2500 PSI or use of nitro compounds, which are highly inflammable and toxic. The purity of 1,2-diamines obtained by above mentioned prior-art is poor, the product obtained is very hygroscopic and difficult to purify without significantly affecting the yields. Thus, the invention provides a process which does not result in impure product; rather pure 1,2-diamines having purity more than 99% by GC is obtained. The process is simple, cost-effective, which does not require high pressure and provide pure non- hygroscopic product thus making the process amenable for commercial use. SUMMARY OF THE INVENTION In one general aspect there is provided a process for preparing 1,2-diamines of Formula I, or a salt thereof,
Figure imgf000004_0001
Formula I
wherein, Rls R2 and R3 are hydrogen or Ci to C6 straight or branched chain alkyl group. The process includes a) hydrogenating acetylamino-nitrile of Formula II,
Figure imgf000004_0002
Formula II wherein Rl5 R2 and R3 are as defined above and R4 is hydrogen or Ci to C6 straight or branched chain alkyl group, with a metal catalyst in the presence of ammonia or chemical equivalents thereof, at a hydrogen gas pressure of about 40 PSI to about 250 PSI, in an organic solvent to get a dihydroimidazole of Formula III,
Figure imgf000005_0001
Formula III wherein Rls R2, R3 and R4 are as defined above; and b) hydrolyzing the dihydroimidazole of Formula III in the presence of a base to get 1 ,2-diamine of Formula I, or a salt thereof. In another general aspect there is provided a process for preparing 2-methyl- 1,2- diaminopropane of Formula I, or a salt thereof, wherein Ri and R2 are methyl and R3 is hydrogen. The process includes a) hydrogenating acetylamino-nitrile of Formula II, wherein R! and R2 are methyl, R3 is hydrogen and R4 is hydrogen or to C6 straight or branched chain alkyl group, with a metal catalyst in the presence of ammonia or chemical equivalents thereof, at a pressure of about 40 PSI to about 250 PSI in an organic solvent to get a dihydroimidazole of Formula III, wherein Rl3 R2, R3 and R4 are as defined above; and b) hydrolyzing the dihydroimidazole of Formula III in the presence of a base to get 2- methyl-l,2-diaminopropane of Formula I, or a salt thereof, wherein Ri and R2 are methyl and R3 is hydrogen. In another general aspect there is provided a process for preparing pure 1,2- diamine of Formula I, or a salt thereof. The process includes drying 1,2-diamine over a solid base and then distilling over a solid base to get the pure 1,2-diamine having a purity of more than 99% by GC. The process may produce the pure 1,2-diamine having a purity of more than 99% by GC. In particular, it may produce 1,2-diamine having a purity of more than 99.5%, for example more than 99.8% by GC. In another general aspect there is provided a pure 1,2-diamine of Formula I, or a salt thereof, wherein R! and R2 are methyl and R3 is hydrogen, having a purity of more than 99% by GC. The pure 1,2-diamine of Formula I, or a salt thereof may have, for example moisture content less than 1% w/w. In particular, it may have moisture content less than 0.5%) w/w, for example less than 0.3% w/w. The resulting pure 1,2-diamine of Formula I, or a salt thereof, may be used as an intermediate for the preparation of dyes, enamels, varnishes, fungicides, bactericides, resins, herbicides, hypoglycemic agents, 3-adrenergic blockers, antipyretics, anti- depressants, anti-diabetics, anti-inflammatory, antimalarials, ulcer-inhibitors, anti- arrhythmic, antihypertensive, anti-secretory compounds, and the like. The details of one or more embodiments of the inventions are set forth in the description below. Other features, objects and advantages of the inventions will be apparent from the description and claims. Detailed Description of the Invention The inventors have developed an efficient process for the preparation of 1,2- diamines of Formula I, or a salt thereof, wherein Rls R2 and R3 are hydrogen or to C6 straight or branched chain alkyl group. The process involves hydrogenating acetylamino- nitrile of Formula II, wherein Rls R2 and R3 are as defined above and Rt is hydrogen or Ci to C6 straight or branched chain alkyl group, with a metal catalyst in the presence of ammonia or chemical equivalents thereof, at a hydrogen gas pressure of about 40 PSI to about 250 PSI, in an organic solvent to get a dihydroimidazole of Formula III, wherein Rl5 R2, R3 and R4 are as defined above. The dihydroimidazole of Formula III is hydrolyzed in the presence of a base to get 1,2-diamine of Formula I, or a salt thereof. The hydrogenation reaction may be carried at a temperature from about 40 °C to about 180°C. In particular, it may be carried out at a temperature from about 60 °C to about 150°C. Examples of metal catalysts which can be used in the hydrogenation reaction include catalysts such as Raney nickel, platinum and ruthenium. Suitable organic solvents which can be used in the hydrogenation reaction of compound of Formula II are conventional solvents used in the hydrogenation reactions and are known to a person of ordinary skill in the art. Examples of such solvents include alcohols, inert polar aprotic solvents, dialkyl ether, paraffin oil, dowtherm, and the like. The term "ammonia or chemical equivalents thereof includes liquor ammonia, aqueous ammonia solution, ammonium hydroxide, ammonium chloride, ammonium sulphate, ammonium formate, and the like. h general, the reaction mixture may be cooled after the completion of the reaction, and may be treated with charcoal. The reaction mixture may also be concentrated to reduce the volume of solvent before cooling. The dihydroimidazole of Formula III thus obtained may be used as such for further hydrolysis. It may also be further purified by high vacuum distillation and the fractions corresponding to the pure dihydroimidazole of Formula III are collected separately and used for further hydrolysis reaction. The hydrolysis of the dihydroimidazole of Formula III can be carried out in aqueous conditions using a base. The reaction may also be carried out in the presence of an organic solvent. The dihydroimidazole of Formula III can be treated with aqueous solution of a base at a temperature of from about 60 °C to 150°C. The organic solvents which can be used in the hydrolysis reaction include water- soluble alcohols, low boiling polar aprotic solvents, water-soluble ketones, acetonitrile, and mixtures thereof. Examples of a base which can be used in the hydrolysis reaction of dihydroimidazole of Formula III include alkali and alkaline earth metal hydroxides, carbonates, bicarbonates and alkoxides. After completion of the reaction, the organic solvent may be removed under vacuum and the 1,2-diamine product layer can be separated from the reaction mass by adding a solid base to the reaction mass. The separated layer can be isolated and dried over solid base for about 10-12 hours. The 1,2-diamine product may be further or additionally dried to achieve the desired moisture values. The product may be dried by removing the solid base drying agent and adding fresh solid base. The resultant mass can be stirred at about 35-40°C to reduce the moisture content to less than 1%. The solid base drying agents which can be used include alkali metal hydroxide such as potassium hydroxide. The inventors have also developed a process for the preparation of 2-methyl- 1,2- diaminopropane of Formula I, or a salt thereof, wherein Ri and R2 are methyl and R3 is hydrogen. The process involves hydrogenating acetylamino-nitrile of Formula II, wherein RΪ and R2 are methyl, R3 is hydrogen and i is hydrogen or Ci to C6 straight or branched chain alkyl group, with a metal catalyst in the presence of ammonia or chemical equivalents thereof, at a pressure of about 40 PSI to about 250 PSI in an organic solvent to get dihydroimidazole of Formula Ul, which is hydrolyzed in the presence of a base to get 2-methyl- 1,2-diaminopropane of Formula I, or a salt thereof, wherein Ri and R2 are methyl and R3 is hydrogen. The product 1,2-diamine thus obtained may be used as an intermediate in the preparation of dyes, enamels, varnishes, fungicides, bactericides, resins, herbicides, hypoglycemic agents, /3-adrenergic blockers, anti-depressants, anti-inflammatory, antimalarials, ulcer-inhibitors, anti-arrhythmic, antihypertensive, anti-secretory compounds, and the like. Acetylamino-nitrile of Formula II wherein, Rl5 R2 and R3 are methyl and R is hydrogen or Ci to C6 straight or branched chain alkyl group can be prepared by methods known in the art such as the process disclosed in U.S. Patent No. 2,587,043. The present invention is further illustrated by the following examples which are provided merely to be exemplary of the invention and do not limit the scope of the invention. Certain modifications and equivalents will be apparent to those skilled in the art and are intended to be included within the scope of the present invention.
Example 1: Preparation of 2,4,4-trimethyl-2,3-dihydroimidazole hi a hydrogenator, N-acetyl-2-cyano-2-methylethylamine (100 gm) and methanol (300 ml) were added followed by addition of Raney Nickel catalyst (80 gm) and liquor ammonia solution (200 ml, 22-25% w/v in water). The vessel was closed and hydrogen gas was purged to achieve 6 Kg pressure. The temperature of the reaction mass was slowly raised up to 85°C. The reaction mass was strrred at 8 to 9 Kg hydrogen pressure at 85 to 90°C for 8 to 9 hrs. After confiπning the completion of reaction by TLC, the reaction mass was cooled to 25 to 30°C and hydrogen was vented out. The reaction mass was removed from the hydrogenator and charcoal (10 gm) was charged to it. The resultant mass was filtered through a celite bed and the bed was washed with a small amount of methanol. The filtrate was concentrated under vacuum to remove methanol and the residue was distilled under vacuum of about 10 mm of Hg and the fraction distilling between 110- 130°C was collected and kept separately to give pure 2,4,4-trimethyl-2,3- dihydroimidazole.
Yield: 80 gm
Purity: Not less than 99% by GC
Example 2: Preparation of 2-methyl- 1,2-propanediamine 2,4,4-trimethyl-2,3 -dihydroimidazole (100 gm) prepared per example 1 was added to a solution of potassium hydroxide (300 ml, 30% w/v in water). The resultant mixture was refmxed for about 6 to 7 hours. The completion of reaction was monitored by TLC. After this, the reaction mass was cooled to about 25-30°C. Solid potassium hydroxide (300 gm) was added to the cooled mass and stnred for about 30 minutes. The organic layer was separated and collected. Solid potassium hydroxide (10 gm) was added to the organic layer. The resultant mass was stiπed further at 35 to 40°C for 10 to 12 hours. Solid potassium hydroxide was filtered and the moisture content of the filtrate was checked. The process of adding solid potassium hydroxide and heating to 35-40°C was repeated till moisture content of not more than 1% was achieved. This gave substantially pure 2- methyl- 1,2-diaminoρropane.
Yield: 85 gm
Purity: not less than 99% by GC
The above-obtained material was distilled at atmospheric pressure and the fraction boiling at 109-111°C was collected to get highly pure 2-methyl- 1,2-diaminopropane. Yield: 82.5 gm Purity: 99.9% by GC
Moisture content: 0.3% w/w by Karl Fischer. While the present invention has been described in terms of its specific embodiments, certain modifications and equivalents will be apparent to those skilled in the art and are included within the scope of the present invention.

Claims

We Claim: 1. A process for the preparation of 1,2-diamines of Formula I, or a salt thereof,
Figure imgf000011_0001
Formula I wherein Ri, R2 and R3 are hydrogen or Ci to C6 straight or branched chain alkyl group, the process comprising: a) hydrogenating acetylamino-nitrile of Formula II,
Figure imgf000011_0002
Formula II wherein Rls R2 and R3 are as defined above and P^ is hydrogen or Ci to Cg straight or branched chain alkyl group, with a metal catalyst in the presence of ammonia or chemical equivalents thereof, at a pressure of about 40 PSI to about 250 PSI, in an organic solvent to get a dihydroimidazole of Formula III,
Figure imgf000011_0003
Formula III wherein Ri, R2, R3 and 4 are as defined above; and b) hydrolyzing the dihydroimidazole of Formula III in the presence of a base to get 1 ,2- diamine of Formula I, or a salt thereof.
2. The process of claim 1, wherein the metal catalyst comprises one or more of Raney nickel, platinum, and ruthenium catalysts.
3. The process of claim 1, wherein the hydrogenation reaction is carried out at a temperature of from about 40°C to about 180°C.
4. The process of claim 1, wherein the dihydroimidazole of Formula III is used as such for further hydrolysis.
5. The process of claim 1, wherein the dihydroimidazole of Formula III is further purified by high vacuum distillation before hydrolysis.
6. The process of claim 1, wherein the organic solvent used in the hydrogenation reaction comprises one or more of alcohols, inert polar aprotic solvents, dialkyl ether, paraffin oil, dowtherm, and mixtures thereof.
7. The process of claim 1, wherein the ammonia or chemical equivalents thereof comprise one or more of liquid ammonia, aqueous ammonia solution, ammonium hydroxide, ammonium chloride, ammonium sulphate, and ammonium formate.
8. The process of claim 1, wherein the base used in the hydrolysis reaction comprises one or more of alkali and alkaline earth metal hydroxides, carbonates, bicarbonates, and alkoxides.
9. The process of claim 1 , wherein the hydrolysis of dihydroimidazole of Formula III is carried out in aqueous conditions using a base.
10. The process of claim 9, wherein the reaction is carried out in the presence of an organic solvent.
11. The process of claim 10, wherein the organic solvent comprises one or more of water- soluble alcohols, low boiling polar aprotic solvents, water-soluble ketones, acetonitrile, and mixtures thereof.
12. The process of claim 9, wherein the dihydroimidazole of Formula III is treated with aqueous solution of a base at a temperature of about 60 to 150°C.
13. The process of claim 1, wherein the 1,2-diamine obtained after step (b) is dried over a solid base-drying agent.
14. The process of claim 13, wherein the solid base drying agent is an alkali metal hydroxide.
15. The process of claim 14, wherein the alkali metal hydroxide is potassium hydroxide.
16. The process of claim 1, wherein the 1,2-diamine of Formula I has a purity of more than 99% by GC.
17. The process of claim 1 , wherein the 1 ,2-diamine of Formula I has moisture content less than 1% w/w.
18. A process for the preparation of pure 1,2-diamine of Formula I, or a salt thereof,
Formula I wherein Ri, R2 and R3 are hydrogen or to C6 straight or branched chain alkyl group, the process comprising drying 1,2-diamine over a solid base and then distilling over a solid base to get a pure 1,2-diamine having a purity of more than 99% by GC.
19. The process of claim 18, wherein the pure 1 ,2-diamine has moisture content less than 1% w/w.
20. A process for the preparation of 2-methyl- 1,2-diaminopropane of Formula I, or a salt thereof,
Figure imgf000013_0002
Formula I wherein Ri and R2 are methyl and R3 is hydrogen, the process comprising: a) hydrogenating acetylamino-nitrile of Formula II,
Figure imgf000014_0001
Formula II wherein, Ri and R2 are methyl; R3 is hydrogen and R4 is hydrogen or Ci to C6 straight or branched chain alkyl group, with a metal catalyst in the presence of ammonia or a chemical equivalent thereof at a pressure of about 40 PSI to about 250 PSI in an organic solvent to get a dihydroimidazole of Formula III,
Figure imgf000014_0002
Formula III wherein, Ri, R2, R3 and R4 are as defined above; and b) hydrolyzing the dihydroimidazole of Formula III, or a salt thereof, in the presence of a base to get 2-methyl- 1,2-diaminopropane of Formula I, wherein Ri and R2 are methyl and R3 is hydrogen.
21. Pure 1 ,2-diamine of Formula I, or a salt thereof,
Figure imgf000014_0003
Formula I wherein Ri and 2 are methyl and R3 is hydrogen, having a purity of more than 99% by GC.
22. The pure 1,2-diamine of claim 21 having a purity of more than 99.5% by GC.
23. The pure 1,2-diamine of claim 21 having a purity of more than 99.9% by GC.
24. Pure 1,2-diamine of Formula I, or a salt thereof,
Figure imgf000015_0001
Formula I wherein Ri and R2 are methyl and R3 is hydrogen, having a purity of more than 99% by GC and moisture content less than 1% w/w.
25. The pure 1,2-diamine of claim 24 having a purity of more than 99.5 % by GC and moisture content less than 1% w/w.
26. The pure 1,2-diamine of claim 24 having a purity of more than 99.9% and moisture content less than 0.3% w/w.
27. A process for the preparation of dyes, enamels, varnishes, fungicides, bactericides, resins, herbicides, hypoglycemic agents, /3-adrenergic blockers, anti-depressants, anti- inflammatory, antimalarials, ulcer-inhibitors, anti-arrhythmic, antihypertensive, anti-secretory compounds using 1,2-diamine as an intermediate prepared according to the process of claim 1, 18 or 20.
PCT/IB2005/001363 2004-05-19 2005-05-19 Process for the preparation of 1,2-diamines WO2005113512A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN905DE2004 2004-05-19
IN905/DEL/2004 2004-05-19

Publications (1)

Publication Number Publication Date
WO2005113512A1 true WO2005113512A1 (en) 2005-12-01

Family

ID=34968474

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/001363 WO2005113512A1 (en) 2004-05-19 2005-05-19 Process for the preparation of 1,2-diamines

Country Status (1)

Country Link
WO (1) WO2005113512A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103748066A (en) * 2011-06-13 2014-04-23 安格斯化学公司 Process for the preparation of alkyldiamines

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2587043A (en) * 1949-01-06 1952-02-26 Bell Telephone Labor Inc Preparation of 1,2 di-primary amines
JPH0827072A (en) * 1994-07-12 1996-01-30 Kuraray Co Ltd Method for producing 2-methyl-1,2-propanediamine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2587043A (en) * 1949-01-06 1952-02-26 Bell Telephone Labor Inc Preparation of 1,2 di-primary amines
JPH0827072A (en) * 1994-07-12 1996-01-30 Kuraray Co Ltd Method for producing 2-methyl-1,2-propanediamine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LINCOLN HAWKINS W. ET AL: "Synthesis of Certain Aliphatic 1,2-Diamines", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 71, no. 7, 1949, pages 2530 - 2531, XP002339298 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103748066A (en) * 2011-06-13 2014-04-23 安格斯化学公司 Process for the preparation of alkyldiamines
US8865941B2 (en) 2011-06-13 2014-10-21 Angus Chemical Company Process for the preparation of alkyldiamines
CN103748066B (en) * 2011-06-13 2017-06-20 安格斯化学公司 The preparation method of alkyl diamine

Similar Documents

Publication Publication Date Title
US7179944B2 (en) Process for preparation of phenethylamine derivatives
EP1907396B1 (en) Method for preparing 4 -amino-4'-demethyl-4-desoxypodophyllotoxin
EP1856036B1 (en) An efficient method for preparation of (s)-3-[(1-dimethyl amino)ethyl]-phenyl-n-ethyl-n-methyl-carbamate
WO2010010359A2 (en) A process for the preparation of cinacalcet and its salts
EP0274324A1 (en) Process for the preparation of thienylethyl amines, and dithienylethyl amines so obtained
CN101155820B (en) Processes for preparing 6,7,8-trihydroxy-1-(hydroxymethyl)-3-oxo-2-oxa-4-azabicyclo[3.3.1]nonane
Maegawa et al. Pd/C (en) catalyzed chemoselective hydrogenation in the presence of aryl nitriles
WO2005113512A1 (en) Process for the preparation of 1,2-diamines
US20050033088A1 (en) Process for the preparation of phenethylamine derivative, an intermediate of Venlafaxine hydrochloride
JPH06298709A (en) Production of n-substituted n'-phenyl-p-phenylene diamine
CZ2008756A3 (en) Process for preparing desvenlafaxine and salts thereof
WO2008065177A1 (en) Processes for preparing desmethylsertraline or a pharmaceutically acceptable salt thereof
FR2734822A1 (en) NEW 2-AZABICYCLO (2.2.1) HEPTANE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION
EP0321349B1 (en) Process for the preparation of n-(2-chloro-benzyl)(2-thienyl)-2-ethyl amine
US6340773B1 (en) Preparation of halogenated primary amines
JP2004507524A (en) Novel method for producing 3-aminomethyl-4-Z-methoxyiminopyrrolidine
EP2121574A1 (en) Improved process for the preparation of phenethylamine derivatives
FR2615853A1 (en) NOVEL PROCESS FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE PIPERAZINE DERIVATIVES, DERIVATIVES AND NOVEL INTERMEDIATES OBTAINED
Cho et al. Ruthenium‐catalyzed formation of quinolines via reductive cyclization of nitroarenes with tris (3‐hydroxypropyl) amine in an aqueous medium
US6710210B2 (en) N-substituted-aminomethyl cyclopropyl ketone derivatives or salts thereof and production process therefor
BE1013317A6 (en) New method of preparation and derivatives piperazine.
KR20050006286A (en) PROCESS FOR PREPARING (S)-TETRAHYDRO-α-(1-METHYLETHYL)-2-OXO-1(2H)-PYRIMIDINEACETIC ACID
CH661499A5 (en) PROCESS FOR THE PREPARATION OF AMINOBENZYLAMINES.
JPH0539249A (en) Production of 1-(3,5-dialkylphenoxy)-2-aminopropane
KR20070012123A (en) Method for producing trans-4-methylcyclohexylamine by catalytic hydrogenation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载